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Natural products constitute important lead
structures in drug discovery. In bacteria, they
are often synthesized by large, modular multi-
enzyme complexes. Detailed analysis of the
biosynthetic machinery should enable its di-
rected engineering and production of desirable
analogs. The myxobacterium Sorangium cellu-
losum So ce90 produces the cytotoxic spiroke-
tal polyketide spirangien, for which we describe
the identification and functional analysis of the
biosynthetic pathway. The gene cluster spans
88 kb and encodes 7 type I polyketide syn-
thases and additional enzymes such as a
stand-alone thioesterase and 2 methyltrans-
ferases. Inactivation of two cytochrome P450
monooxygenase genes resulted in the produc-
tion of acyclic spirangien derivatives, providing
direct evidence for the involvement of these en-
zymes in spiroketal formation. The presence of
large DNA repeats is consistent with multiple
rounds of gene duplication during the evolution
of the biosynthetic gene locus.
INTRODUCTION
The need for new therapeutic agents continues to be
pressing. Bioactive natural products obtained from micro-
organisms are common sources of such medicines, but
the metabolites often also serve as lead structures for
drug development [1]. Prominent among these com-
pounds are the polyketides, which are biosynthezised by
polyketide synthases (PKSs) from simple acyl-CoA thio-
ester building blocks [2]. The bacterial type I class of
PKSs exhibits an assembly line architecture, in which each
module within the large multienzymes (usually) catalyzes
a single round of chain extension and reductive process-
ing. Thus, the genetic organization is colinear with the se-
quence of biosynthetic transformations [3]. Each module
contains an acyl transferase (AT) domain responsible for
selection of extender units and a ketosynthase (KS) do-Chemistry & Biology 14, 22main that incorporates the building blocks into the grow-
ing chain via a Claisen-like condensation reaction. The
third essential domain within each module is the acyl car-
rier protein (ACP) to which the intermediates are tethered
in thioester linkages via the phosphopanthetheine pros-
thetic arm. The modules optionally incorporate domains
for reductive modification of the b-keto functionalities as
in fatty acid biosynthesis [2], including ketoreductase
(KR), dehydratase (DH), and enoyl reductase (ER) activi-
ties. The precise complement of these elements deter-
mines the overall extent of reduction to a b-hydroxyl, an
a,b double bond, or a fully reduced methylene. The com-
pletely processed polyketide chain is usually released
from the enzyme complex by a C-terminal thioesterase
(TE) domain through intramolecular lactonization or hydro-
lysis. Frequently, the enzyme-free intermediate is then
modified by a series of regio- and stereospecific ‘‘tailor-
ing’’ reactions such as methylation, oxidation, and glyco-
sylation, which is usually important for the bioactivity [4].
The pharmacological and physiochemical properties of
natural products can often be enhanced by modifying their
structures, which may be essential for the therapeutic ap-
plication. As natural products exhibit a high degree of
structural and stereochemical complexity, preparation
by total synthesis represents a significant challenge. A
more economically viable alternative is to generate ana-
logs by ‘‘semisynthesis,’’ starting from existing structures
[5]. A potentially powerful alternative strategy is to genet-
ically engineer the polyketide pathways in order to rear-
range the assembly lines in a targeted manner. The mod-
ular organization of type I PKSs makes them ideal
candidates for approaches aimed at deleting, swapping,
and mutating individual domains and modules [3]. Modifi-
cation of the PKS assembly line can give rise to shortened
scaffolds, altered stereochemistry, and compounds de-
rived from new combinations of building blocks.
Tailoring enzymes have been used extensively for com-
binatorial biosynthesis, as they are easier to target than
domains within the megasynthases, and the outcome of
modifying their functions tends to be more predictable.
These enzymes can be inactivated, mutated, replaced,
or substituted with tailoring enzymes from other path-
ways, giving rise, for example, to molecules with altered
oxidation states or glycolsylation patterns [3, 6]. Such1–233, February 2007 ª2007 Elsevier Ltd All rights reserved 221
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very difficult to achieve by standard synthetic chemistry,
and they may also generate advanced intermediates for
use in medicinal chemistry. Progress and challenges in
the field recently have been described in two excellent
reviews [3, 6].
Nature itself exploits the flexibility of modular systems,
as demonstrated by the increasing number of PKS sys-
tems that exhibit deviations from colinearity, for example,
by skipping or iterative use of modules [7, 8]. Although
much has been discovered about these systems over
the last decade, the analysis of newly sequenced gene
clusters continues to reveal novel features of the biosyn-
thetic pathways. However, to take full advantage of the
opportunities Nature offers for combinatorial biosynthesis
of altered compounds, it will be essential to decipher the
molecular logic of polyketide assembly in significantly
greater detail.
The genes that encode PKSs, tailoring enzymes, and
other proteins involved in the biosynthesis of polyketides
are usually found clustered on the chromosome, which
eases their identification and analysis. With the sequenc-
ing of increasing numbers of microbial genomes, potential
biosynthetic gene clusters can be identified through in
silico analysis. However, a more common strategy is to
screen genomic libraries for the presence of highly con-
served genes within the PKSs [9].
Myxobacteria are ubiquitous in soil and are proficient
producers of natural products with various biological ac-
tivities. Interestingly, most of the myxobacterial secondary
metabolites have been isolated from the genus Sorangium
[10]. The complex life cycle of these bacteria and their ex-
traordinary ability to produce secondary metabolites is
mirrored by their enormous genome size. The 13.1 Mbp
genome of the model strain Sorangium cellulosum
So ce56 is the largest yet discovered in bacteria (S. cellu-
losum genome project within the BMB+F Genomik net-
work, unpublished data and [11]). The challenges with
Sorangium sp. are difficult handling, slow growth (genera-
tion times from 8 to 16 hr), and limited tools for genetic
manipulation [12]. S. cellulosum So ce90 produces the
epothilones, which are hybrid natural products derived
from PKSs and nonribosomal peptide synthetases
(NRPSs) [13, 14]. The epothilones are currently in phase
III clinical trials as anticancer agents and are expected to
replace taxol-derived agents once they are approved for
human therapy [15].
In this article, we describe the identification and the
analysis of the biosynthetic genes for the spiroketal poly-
ketide spirangien (Figure 1) [16] from S. cellulosum
So ce90. To analyze the function of the PKS and non-
PKS enzymes involved, site-directed mutagenesis was
performed to inactivate the corresponding genes, result-
ing in the production of a number of new, to our knowl-
edge, spirangien derivatives. Structure elucidation re-
vealed two sets of desmethyl derivatives and an acyclic
compound, which was also produced in the glycosylated
form. The spirangien PKS genes contain large stretches
of sequence repeats, suggesting that the gene cluster in222 Chemistry & Biology 14, 221–233, February 2007 ª2007 Elsits current form evolved from a smaller ancestor by several
gene duplication events. This may reflect the way Nature
uses the flexibility of modular megasynthetases to de-
velop compounds that offer evolutionary benefits to their
producing organisms.
RESULTS AND DISCUSSION
Identification of the Spirangien Biosynthetic
Gene Cluster
Among PKS domain sequences, those encoding KS do-
mains are highly conserved. Screening of a cosmid geno-
mic library of S. cellulosum So ce90 consisting of about
1600 clones with probes derived from KS sequences
[17] led to the identification of the overlapping cosmids
c77 and c66. Both cosmids were sequenced [17] and
were found to contain 47 kb of sequence encoding the
30 end of a modular PKS biosynthetic gene cluster (Fig-
ure 1A). Site-directed mutagenesis of the KS-encoding
sequence from spiH, by integration of plasmid pJKB16
into the chromosome of S. cellulosum So ce90, resulted
in loss of spirangien production (for the construction of
plasmids, see Table S1 in the Supplemental Data available
with this article online). Restriction analysis and end se-
quencing of cosmid c48, also identified during the screen,
revealed a 30 kb overlap with c77. A fragment of the T7
end of cosmid c48 was used to screen a second cosmid
library from S. cellulosum So ce90 consisting of another
2300 clones, and screening led to the identification of cos-
mid c4O20. This cosmid was sequenced and was found to
harbor the 50 end of the gene cluster. The remaining 3.8 kb
gap was amplified from cosmid c48 by PCR and was
sequenced after cloning to give pSpiL.
Sequence Analysis of the Spirangien Biosynthetic
Gene Cluster
The spirangien biosynthetic gene cluster is 88.4 kb in size
and shows an overall G+C content of 74.8%. Seven type I
PKS-encoding genes, spiDEFGHIJ, are flanked by a set of
three adjacent genes on each side of the gene cluster
(Figure 1A; Table 1). spiA and spiB are located on the com-
plementary strand, and the deduced proteins show se-
quence similarities to type II thioesterases and O-methyl-
transferases, respectively. Located directly upstream of
spiD is spiC, coding for a cytochrome P450 monooxyge-
nase. A second O-methyltransferase and another cyto-
chrome P450 monooxygenase are encoded by spiK and
spiL, respectively. spiZ is located on the complementary
strand, and the encoded protein shows similarities to
sigma factors.
Deciphering the Biosynthetic Logic of Spirangien
Biosynthesis: Analysis of the PKS
The polyketide scaffold of spirangien is synthezised by 7
PKSs (SpiDEFGHIJ) harboring a loading module with an
unusual organization, 15 additional modules for the incor-
poration of extender units, and a terminal TE domain (Fig-
ure 2). Thus, the modular arrangement of the PKS follows
the colinear paradigm, as 16 building blocks are requiredevier Ltd All rights reserved
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Spiroketal Polyketide Formation in S. cellulosumFigure 1. Organization of the Spirangien Biosynthetic Gene Cluster and Structures of Spirangien and Derivatives
(A) The inserts of cosmids c4O20, c71, and c66 and of plasmid pSpiL are indicated by lines. Seven polyketide synthase-encoding genes (light gray)
are surrounded by two sets of adjacent genes (dark gray). The open reading frame orf1 is incomplete (no stop codon). The deduced functions of the
proteins encoded are listed below.
(B) Structures of spirangienes A and B.
(C) Acyclic derivatives produced by the spiL knockout mutant JKB19.
(D) Desmethylderivatives produced by the spiK knockout mutant BFSK.
(E) Desmethylderivatives produced by the spiB knockout mutant BFSB.to assemble the spirangien core. The domain organization
of most of the modules also correlates well with the spiran-
gien structure, with only few exceptions. The organization
of SpiD (ACPL-KS-ATL-AT-DH.) is unusual, but the same
domain order is also present in other myxobacterial bio-
synthetic gene clusters [18–20]. In this module, the cata-
lytic domains for the loading of the starter unit (ACPL
and ATL) and the corresponding domains for the first
elongation step seem to be mixed. The modules down-
stream of module L1 all contain the minimal set of PKS
elongation domains (KS-AT-ACP) in the standard arrange-
ment, as well as combinations of the optional reductive
domains (KR, DH-KR, or the complete ‘‘reductive loop’’
DH-ER-KR).
The ACPL (as all ACP domains present in the cluster)
displays the highly conserved serine residue that is
required for the conversion into its active holo form by
attachment of a 4-phosphopantetheinyl arm [2]. The AT
domains are responsible for selection of the acyl-CoAs
and their transfer to the ACPs. All AT domains present con-
tain the highly conserved active site GHSxG motif. Exten-Chemistry & Biology 14, 221–sive sequence analysis of AT domains specific for methyl-
malonyl-CoA or malonyl-CoA has revealed a number of
conserved residues [21] that seem to correlate with sub-
strate specificity. A serine residue in position 200 (accord-
ing to [21]) is highly conserved in the AT domains that select
methylmalonyl-CoA, whereas AT domains specific for ma-
lonyl-CoA display a conserved phenylalanine residue at
the equivalent position. The presence of these residues
can therefore be used to predict the substrate specificity
of newly sequenced AT domains. The pattern of malonyl-
CoA and methylmalonyl-CoA incorporation predicted by
sequence analysis of the AT domains in each module ex-
actly matches that found in the spirangienes (the ATs of
modules 5, 6, 10, 11, 12, 13, 14, and 15 are malonyl-CoA
specific, while those of modules 1, 2, 3, 4, 7, 8, and 9 are
methylmalonyl-CoA specific). The ATL differs from the
ATs in elongation modules at a number of conserved resi-
dues (Figure S1), consistent with its ability to select both
acetyl-CoA and propionyl-CoA starter units (Figure 2).
KR domains are present in all chain-extension modules,
and they exhibit a typical NADPH-binding site [22] and233, February 2007 ª2007 Elsevier Ltd All rights reserved 223
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PKS Part of the Spirangien Biosynthetic Gene Cluster
Protein (Gene) Size (Da/bp) Proposed Function (Protein Domains with Their Position in the Sequence)
SpiD (spiD) 470,885/13,602 ACP (214–411), KS (499–1776), AT (2,056–2,946), AT (3,409–4,299),
DH (4,492–4,989), KR (5,974–6,510), ACP (6,847–7,020), KS (7,090–8,370),
AT (8,698–9,588), DH (9,784–10,293), ER (11,335–12,258), KR (12,289–12,825),
ACP (13,138–13,338)
SpiE (spiE) 356,285/10,281 KS (106–1,365), AT (1,684–2,577), KR (3,616–4,148), ACP (4,477–4,677),
KS (4,765–6,039), AT (6,367–7,266), DH (7,465–7,977), KR (8,959–9,495),
ACP (9,808–10,008)
SpiF (spiF) 172,992/4,953 KS (97–1,371), AT (1,699–2,604), KR (3,613–4,149), ACP (4,483–4,683)
SpiG (spiG) 554,784/15,996 KS (103–1,383), AT (1,720–2,634), KR (3,670–4,203), ACP (4,522–4,722),
KS (4,804–6,084), AT (6,412–7,302), DH (7,498–7,995), ER (9,028–9,951),
KR (9,982–10,518), ACP (10,858–11,031), KS (11,113–12,387), AT (12,718–13,611),
KR (14,644–15,180), ACP (15,520–15,720)
SpiH (spiH) 524,296/15,018 KS (73–1,353), AT (1,672–2,562), KR (3,598–4,131), ACP (4,450–4,650),
KS (4,732–6,012), AT (6,331–7,230), KR (8,257–8,793), ACP (9,133–9,333),
KS (9,421–10,701), AT (11,014–11,919), DH (12,155–12,621),
KR (13,699–14,235), ACP (14,554–14,754)
SpiI (spiI) 366,953/10,542 KS (115–1,389), AT (1,717–2,628), KR (3,658–4,194), ACP (4,522–4,722),
KS (4,813–6,093), AT (6,436–7,341), DH (7,537–8,037), KR (9,154–9,690),
ACP (10,009–10,209)
SpiJ (spiJ) 374,780/10,740 KS (106–1,377), AT (1,705–2,616), DH (2,815–3,312), KR (4,354–4,890),
ACP (5,209–5,406), KS (5,482–6,755), AT (7,072–7,980), KR (8,839–9,375),
ACP (9,670–9,870), TE (10,117–10,722)
Proteins Encoded Upstream of spiC and Downstream of spiJ
Protein
(Gene) Size (Da/bp)
Proposed Function
of the Similar Protein
Sequence Similarity
to Source
Similarity/Identity
(Amino Acids)
Accession Number
of the Similar Protein
SpiA (spiA) 29,789/792 putative thioesterase Nostoc sp. 56%/36% (241) NP_486085.1
SpiB (spiB) 35,748/963 possible
methyltransferase
Mycobacterium bovis 51%/39% (220) NP_856621.1
SpiC (spiC) 51,172/1,434 probable C-type
cytochrome
Pseudomonas
aeruginosa
39%/30% (229) NP_253309.1
SpiK (spiK) 28,863/792 putative
methyltransferase
Hypothetical symbiont
bacterium of Paederus
fuscipes
56%/42% (188) AA547557.1
SpiL (spiL) 50,503/1,368 cytochrome P450 Trichodesmium
erythraeum
61%/40% (447) ZP_00675674.1
SpiZ (spiZ) 23,414/639 sigma-24 factor Anaeromyxobacter
dehalogenans
55%/40% (158) YP_464957.1a conserved Lys-Ser-Tyr-Asn catalytic tetrad [23]. On the
basis of amino acid motifs that seem to correlate with the
stereochemistry of ketoreduction, KR domains can be
classified as A or B type. The most diagnostic residue
for B-type ketoreduction is an aspartate at position 95
[24], and double bonds derived from dehydration of the re-
spective hydroxyl groups are expected to have an E (trans)
configuration. Correspondingly, A-type domains lack this
conserved Asp, and dehydration of an A-type hydroxyl
could directly yield a Z (cis) double bond [23–25]. The spi-
rangien PKS appears to fit with this model, as dehydration
of hydroxyl intermediates generated by B-type KRs (mod-
ules 1, 11, and 13) appears to give rise to E double bonds,224 Chemistry & Biology 14, 221–233, February 2007 ª2007 Ewhile the double bonds generated after A-type reduction
(modules 10 and 12) are uniformly in Z configuration.
DH domains are present in modules 1, 2, 4, 7, 11, 13,
and 14 and display the conserved active site motif
LxxHxxxGxxxxP, which is characteristic of the enzyme
family (Figure 2) [26]. However, in order to generate the
conjugated double bond system in the spirangien struc-
ture, DH activity is also required after chain extension by
modules 10 and 12. We assume that in these cases elim-
ination of water is catalyzed by the DH domains of the
downstream modules 11 and 13, respectively. The DH do-
mains of modules 11 and 13 show high similarity to each
other (69%), and phylogenetic analysis reveals that theylsevier Ltd All rights reserved
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Biosynthesis of spirangien B is supposed to occur analogously, but starting with ACPL-bound propionate. The DH domain of module 4 is presumably
inactive. AT-KR/DH-KR/DH-ER linker regions are inscripted ‘‘L.’’ For discussion and further abbreviations, see the text.Chemistry & Biology 14, 221–233, February 2007 ª2007 Elsevier Ltd All rights reserved 225
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(Figure S2). Such a scenario (of a DH domain acting exter-
nally of the module it is located in) was also proposed for
stigmatellin biosynthesis in the myxobacterium Stigma-
tella aurantiaca [18], as well as for chivosazol biosynthesis
in S. cellulosum So ce56 [27]. In the chivosazol PKS, the
modules bearing the putative iterative DHs display an un-
usual domain organization, which is not observed in the
spirangien PKS. Experimental evidence to support an iter-
atively acting DH domain has been provided by Tang et al.
for the DH of module 5 from the epothilone mixed PKS-
NRPS pathway [28]. Although the DH domains of modules
11 and 13 appear to operate iteratively, the stereochemis-
try of double bonds generated in the two cycles differs (Z
then E), consistent with the idea that the configuration of
the hydroxyl group determines the stereochemistry of
the dehydration reaction. However, there are cis/trans iso-
mers of spirangienes A and B present in the culture broth
(B.F. and R.M., unpublished data). Although it cannot be
excluded that respective isomerizations occur during the
work up procedure, this finding indicates again [27] that
the classification of KR domains as A or B type cannot
serve as an absolute predictor for double bond stereo-
chemistry.
The DH domain of module 4 contains the typical con-
served active site motif. However, the corresponding hy-
droxyl group appears to be retained in the structure. It is
likely to be involved in spiroketal formation, because
a knockout mutant of the P450-dependent monooxyge-
nase gene spiL produces acyclic spirangienes with a (par-
tially glycosylated) hydroxyl group at the corresponding
carbon (C-25) (Figure 1C). Point mutations adjacent to
the core amino acids of the module 4 DH domain
(Figure S2) may be responsible for this loss of function.
The last module of the spirangien assembly line (module
15) terminates in a TE domain. The TE contains the con-
served GXSXG motif characteristic of this family of en-
zymes [29] and most likely catalyzes the hydrolytic release
of the fully processed polyketide chain from the multien-
zyme complex, yielding the free acid.
All modules of the spirangien PKS harbor long linker re-
gions at the N terminus of the KR domains or, if present,
ER domains (Figure 2). These domains span 380 aa,
share a number of conserved residues and motifs (as
G302LxRxxxxE and E352xxxAL/VR), and can be clearly di-
vided into two groups based on sequence comparison.
One group comprises the linker regions of modules 1, 2,
4, 7, 11, 13, and 15, and the other group comprises the
linker regions of modules 3, 5, 6, 8, 9, 10, 12, and 14. How-
ever, the grouping of the domains reveals no obvious bio-
synthetic logic. These kinds of DH-KR/DH-ER linker re-
gions are frequently found in bacterial PKSs and are
believed to contribute to intramolecular (and possibly
also intermolecular) protein-protein interaction [30]. The
structure of the KR domain including the linker region
from the first module of the erythromycin PKS has been
solved recently [30] and suggests a structural role for the
linker region by stabilizing the catalytic part of the KR
domain.226 Chemistry & Biology 14, 221–233, February 2007 ª2007 ElsTailoring Reactions in Spirangien Biosynthesis
The biosynthesis of the polyketide scaffold by the PKS as-
sembly line is followed by a series of tailoring reactions.
Spirangien displays four functional groups that are unlikely
to derive from PKS reactions: two methoxy groups in po-
sitions 3 and 23, a hydroxyl group in position 20 (C-20
originates from C-2 of the incorporated acetate unit),
and the spiroketal function in the center of the molecule
(Figure 1). Four enzymes encoded in regions that flank
the PKS genes could be responsible for the introduction
of these modifications: SpiB and SpiK show homology
to O-methyltransferases and display the typical S-adeno-
sylmethionine (SAM)-binding motif [31], whereas SpiC and
SpiL resemble cytochrome P450 monooxygenases. To as-
sign the exact function of these proteins in spirangien bio-
synthesis, the corresponding genes were inactivated sep-
arately by site-directed mutagenesis. Manipulation of
Sorangium strains is difficult to achieve, as only limited ge-
netic tools are available [12]. The most commonly used se-
lection markers are not applicable to S. cellulosum
So ce90 because of its broad resistance spectrum. In
addition, to date no self-replicating units have been iden-
tified for myxobacteria. To achieve gene inactivation,
pSUPHyg-based constructs harboring a fragment for
homologous recombination and a hygromycin-resistance
gene [32, 33] were introduced into S. cellulosum So ce90
via biparental mating. Correct integration into the chromo-
some was verified by Southern blot analysis, and the mu-
tants were evaluated for secondary metabolite production
after cultivation in the presence of XAD adsorber resin. A
summary of the mutants generated in this work and their
corresponding phenotypes is given in Table 2.
The inactivation of both putative methyltransferase
genes, spiB and spiK, resulted in the loss of production
of spirangienes A and B. However, new derivatives were
produced with molecular weights that were 14 mass units
below that of the wild-type metabolites (Figure 3), indicat-
ing that each methyltransferase is responsible for the
generation of one of the methoxy groups at positions 3
and 23. The level of production of spirangienes in the
wild-type and derivatives in the mutants was comparable.
In order to assign each methyltransferase to a specific
methylation event, feeding experiments were performed
with L-[methyl-13C]methionine. Spirangien-enriched frac-
tions obtained from these experiments were analyzed by
13C NMR spectroscopy and were compared to the corre-
sponding wild-type fractions. As both acetyl-CoA and
propionyl-CoA serve as starter units in spirangien biosyn-
thesis and additional isomers with variations in double
bond configurations are present (B.F. and R.M., unpub-
lished data), signals corresponding to the 3-OMe group
were present between 56.7 and 57.0 ppm in the 13C
NMR spectrum of the wild-type spirangienes (Figure S4).
As expected, signals for the 23-OMe and 3-OMe groups
were observed in the wild-type sample from the feeding
experiment, while the spectra of fractions derived from
the mutants each lacked one of the signals. In the case
of the spiB knockout mutant, the 23-OMe-derived signal
was missing, whereas the sample from the spiK knockoutevier Ltd All rights reserved
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Mutant
Plasmid for
Inactivation Inactivated Gene (Deduced Function) Phenotype
BFSA pBFS_A spiA (type II thioesterase) spirangien production
BFSB pBFS_B spiB (methyltransferase) production of 23-desmethyl spirangienes
BFSC pBFS_C spiC (cytochrome P450 monooxygenase) no spirangien production
BFSCP pBFS_CP see text and Figure 4 spirangien production
JKB18 pJKB16 spiH (PKS: KS module 10) no spirangien production
BFSK pBFS_K spiK (methyltransferase) production of 3-desmethyl spirangienes
JKB19 pJKB29 spiL (cytochrome P450 monooxygenase) production of acyclic spirangien
derivatives
This work is the reference for all mutants.mutant did not exhibit the 3-OMe-derived signal (Fig-
ure S4). Therefore, it can be concluded that SpiB is re-
sponsible for methylation of the C-23 OH group and that
SpiK catalyzes methyl group transfer to the C-3 hydroxyl
in spirangienes (Figures 1D and 1E). In addition to the se-
quence-based analysis, incorporation of the 13C methyl
group derived from methionine also provides direct evi-
dence that both methyltransferases act in a SAM-depen-
dent manner.
The timing of formation of the spiroketal in spirangien
biosynthesis is currently unknown. The two cytochrome
P450 monooxygenases SpiC and SpiL are most likely in-
volved in the introduction of the hydroxyl group at carbon
20 and the formation of the neighboring spiroketal func-
tion, with C-21 as the central carbon atom. To decipher
the function of SpiC and SpiL in spirangien biosynthesis
and to elucidate the mechanism of spiroketal formation,
site-directed mutagenesis was performed to generate
knockout mutants of both SpiC and SpiL. The knockout
mutant of SpiL (JKB19) failed to produce spirangienes A
and B, but two new derivatives, produced at the wild-
type level, were detected. Structure elucidation by NMR
Figure 3. HPLC Chromatograms of Culture Extracts of Wild-
Type S. cellulosum So ce90, the spiL Knockout Mutant
JKB19, and the spiB Knockout Mutant BFSB11
Spirangiens A and B and derivatives were detected by UV absorption
at 334 nm and mass analysis. The multiple peaks that correspond to
spirangienes A and B and their derivatives originate from different
cis/trans isomers (data not shown).Chemistry & Biology 14, 221analysis after fermentation (4 l) revealed new acyclic deriv-
atives missing the hydroxyl group at carbon 20. One of the
seco derivatives is glycosylated with a pentose at the 25-
OH position, which is normally part of the spiroketal func-
tionality in spirangienes A and B (Figures 1C and 5). Accord-
ing to NMR reference data from the literature, the sugar
moiety is most likely a methylated a-D-arabinofuranoside
[34]. To our knowledge, this compound represents the first
example of a glycosylated metabolite from S. cellulosum
So ce90. However, the same sugar moiety is also part of
the metabolite icumazol B, produced by anotherS. cellulo-
sum strain [35]. After inactivation of spiC, neither spiran-
gien nor cyclic or acyclic derivatives could be detected.
SpiC is encoded 13 bp upstream of the PKS SpiD, indi-
cating that the genes are transcriptionally linked (Fig-
ure 4A). To ensure transcription of the PKS-encoding
genes in the knockout mutant, the aphII promoter [33]
was joined to the fragment used for homologous recombi-
nation (Figure 4B). To exclude the possibility that
Figure 4. Organization of spiC and spiD in Wild-Type and
Mutants of S. cellulosum So ce90
(A) Wild-type. The first PKS-encoding gene, spiD, starts 13 bp down-
stream of spiC and seems to be controlled by the same promoter
(gray).
(B) The spiC kockout mutant BFSC. To ensure transcription of the
PKS-encoding genes, the aphII promotor (black) was cloned 50 of
the homologous fragment for recombination in the spiC knockout mu-
tant BFSC. The asterisk indicates an introduced stop codon, resulting
in two inactive copies of spiC. The vector backbone sequence is indi-
cated by a wiggly line.
(C) The complementation mutant BFSCP. The mutant BFSCP harbors
an intact copy of spiC under the control of the natural promoter, and
the PKS-encoding genes are under the control of the introduced aphII
promoter.–233, February 2007 ª2007 Elsevier Ltd All rights reserved 227
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was inefficient, a second construct for homologous re-
combination, which harbors additional 399 base pairs re-
sembling the missing 30 end of spiC (pBFS_CP), was de-
signed. Integration of pBFS_CP results in a genotype
with one intact copy of spiC controlled by the natural pro-
moter, and a second inactive copy of spiC that is con-
nected to spiD and controlled by PaphII (Figure 4C). In the
corresponding mutant BFSCP, spirangien production
was restored, indicating that PaphII promotes sufficient
transcription of the PKS-encoding genes (an overview of
plasmids, mutants, and phenotypes is given in Table 2).
Thus, it can be concluded that SpiC is essential for spiran-
gien biosynthesis.
In principle, cytochrome P450-catalyzed oxidation and
spiroketal formation could occur during chain assembly
on the PKS, or alternatively after the intermediate is re-
leased from the multienzyme. Inactivation of SpiL leads
to the production of an acyclic spirangien derivative that
resembles a fully processed polyketide chain that has
been released by the terminal TE domain of the PKS
(and further decorated with both methoxy groups). The
glycosylated derivative presumably arises because of
the promiscuous activity of a glycosyl transferase belong-
ing to some other biochemical pathway. Production of
such acyclic intermediates by the SpiL knockout mutant
supports the hypothesis that oxidative modification by
SpiL and SpiC occurs after hydrolytic chain release from
the multienzyme complex.
Spiroketal moieties are present in some other polyke-
tide-derived natural products such as the avermectins
and related compounds produced by Streptomyces aver-
mitilis [36]. In these cases, the spiroketal function is
thought to derive from nucleophilic attack of two hydroxyl
groups on a central carbonyl carbon, resulting in the for-
mation of a hemi-acetal that is then converted to the final
acetal moiety. A different mechanism has been postulated
for the formation of the spiroketal moieties in the polyke-
tide monensin, produced by Streptomyces cinnamonen-
sis. Recent findings indicate that after epoxidation of
PKS-derived double bonds, two epoxide hydrolase-like
enzymes, MonBI and MonBII, catalyze nucleophilic attack
of a hemiacetal-derived hydroxy group on an epoxide car-
bon. This attack results in the formation of an acetal and
concomitant ring opening of the epoxide to generate
a free hydroxyl group, which can subsequently attack
a second epoxide, resulting in the typical polyether struc-
ture found in monensin [37].
In the linear precursor to monensin and avermectin,
a keto group, which ultimately gives rise to the spiroketal
functionality, is present at the carbon center. However,
based on sequence analysis, there is no indication that
the KR domain of module 6 in the spirangien PKS is inac-
tive. Thus, it is unlikely that a keto group is retained at C-21
during chain assembly; therefore, a similar mechanism of
spiroketal formation to the avermectin hypothesis would
have to involve the reintroduction of the keto group by
a tailoring enzyme [36]. Although it cannot be excluded
that spirangien biosynthesis involves an epoxidation228 Chemistry & Biology 14, 221–233, February 2007 ª2007 Elsstep comparable to monensin biosynthesis, SpiL and
SpiC show no significant similarities to epoxidases and
epoxide hydrolases, and no such enzymes are encoded
near the spirangien biosynthetic gene locus.
Further investigation will be required to fully explain the
formation of the spiroketal moiety, but based on the avail-
able evidence, we propose the following two alternative
mechanisms. SpiL may act first by directly or indirectly
reoxidizing the alcohol at C-21 to a keto group, followed
by spontaneous or enzyme-catalyzed cyclization, giving
rise to the spiroketal moiety (hypothetical reaction
schemes are depicted in Figure 5, the ketogroup intro-
duced at C-21 is shown in a hydrated form). In this
Figure 5. Hypothetical Pathways of Spiroketal Formation in
Spirangien Biosynthesis, Starting with the Acyclic Derivative
Produced by the spiL Mutant
The single reactions may be catalyzed by SpiL or SpiC or may occur
spontaneously.evier Ltd All rights reserved
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(A) Location of the repetitive DNA regions within the cluster in relation to the encoded domains.
(B) Degree of identity and length of the single repeats and stretches of repeats.
(C) Sequence repeats were identified by dot plot analysis of the PKS core cluster: the DNA sequence is compared with itself, and regions with a certain
degree of similarity (>85%/30 bp) are pictured as stretches. The diagonal line shows the matching of every residue with itself and is therefore not of
interest for the analysis of repeats.scenario, SpiC would not be capable of introducing a sec-
ond hydroxyl group to C-21; thus spiL inactivation would
lead to the production of the acyclic spirangienes. Alterna-
tively, SpiL may hydroxylate C-20 before SpiC performs
oxidation/cyclization reactions. Here, inactivation of spiL
would also lead to a substrate that cannot be processed
by SpiC. It is also conceivable that SpiC acts first in spiro-
ketal formation by either mechanism. Unfortunately, no
product can be found in the spiC mutant that might clarify
the type of modification introduced by SpiL or SpiC. The
intermediate may be unstable and may break up into
products that are readily degraded in the cells or after ex-
cretion into the medium. In fact, spirangienes themselves
are already unstable compounds.
SpiA Is Not Essential for Spirangien Biosynthesis
The gene product of spiA shows homology to type II thio-
esterases, which are often found in PKS and NRPS bio-
synthetic gene clusters [38]. In contrast to type I thio-
esterases, which catalyze the release of the fully
processed polyketide chain from the multienzyme com-
plex, type II TEs are not thought to be directly involved in
biosynthesis. Inactivation of these enzymes can lead toChemistry & Biology 14, 221decreased product yields as in tylosin biosynthesis [39];
however, in other cases, no effect on product formation
has been observed (e.g., for pikAV from the pikromycin
cluster [40]). Inactivation of spiA also leads to no signifi-
cant effect on spirangien production. Type II thioesterases
have been proposed to play an editing role in polyketide
pathways by removing aberrantly decarboxylated ex-
tender units from the ACPs that would otherwise block
the biosynthesis [38], or by removing certain alternative
starter units from the ACP of the loading module [41]. An-
other possible function of type II TEs is to prevent the ac-
cumulation of intracellular acyl-CoA [42]. Type II TEs in-
volved in nonribosomal peptide biosynthesis have been
characterized in more detail [43], and they were shown
to regenerate misacylated NRPSs [44]. The exact function
of SpiA, and type II TEs in polyketide biosynthesis more
generally, remains unclear.
Sequence Repeats: Indications for the Origin
of Spirangien Biosynthesis?
Dot plot analysis of the PKS portion of the spirangien bio-
synthetic gene cluster reveals the presence of seven large
stretches of sequence that are repeated at least once in–233, February 2007 ª2007 Elsevier Ltd All rights reserved 229
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99.9% identity to each other on the nucleic acid level, and
they vary in size from 1.0 to 4.6 kb. The different repeat re-
gions are clustered in three stretches that are 8.0, 4.1, and
8.2 kb in size; the mutual sequence identity between the
corresponding regions is 86.2%, 78.2%, and 90.1%, re-
spectively (Figure 6B). The first 8.0 kb stretch of repeats
is present at the junctions between both modules 2 and
3 and between modules 7 and 8, and it spans from AT
to AT (Figure 6A). The second repeat region is spanning
spiF completely plus the part of spiH coding for the mod-
ule 10. The third stretch of repeats forms the junctions be-
tween modules 11 and 12 and between modules 13 and
14. The 2 kb of the 30 region encode for a KS-AT didomain
and is additionally found in module 15; the mutual se-
quence identity is 99.4% for modules 12 and 14 and
98.6% for modules 12 and 15.
Sequence repeats with nearly 100% identity on the nu-
cleotide level have also been found in other biosynthetic
gene clusters, but they are mostly restricted to single do-
mains [45, 46]. Examples from myxobacteria include the
myxothiazol and the epothilon biosynthetic gene clusters
[13, 14, 19]. A remarkable and so far unique exception is
the mycolactone biosynthetic gene cluster sequenced
from Mycobacterium ulcerans [47], in which two giant
PKSs, MLSA and MLSB, harbor nine and eight modules,
respectively. All 17 modules represent 6 groups sharing
>98% homology. The arrangement of the modules with re-
spect to these groups appears to be almost random in the
gene cluster, which poses the question of the substrate
specificity of domains within this megasynthetase.
The strong conservation of PKS function is naturally mir-
rored in a certain degree of sequence homology. How-
ever, the extent of sequence repetition in the spirangien
biosynthetic gene cluster is striking. Based on the location
and size of these DNA repeats, one can speculate that the
spirangien biosynthetic gene cluster has evolved through
three major duplication events. An ancestral gene locus
may have comprised 11 modules instead of the 16 mod-
ules present today. It can be assumed that sequence re-
peats with lower overall homology arose from earlier dupli-
cations, while stretches with very high similarity derive
from more recent events. Strongly conserved regions
within the repeat stretches are interrupted by less con-
served regions that may be more tolerant to the accumu-
lation of point mutations over generations. A first duplica-
tion event involving module 2 and portions of module 3
may have resulted in the corresponding regions of mod-
ules 7 and 8, while duplication of module 5 may have re-
sulted in module 10. The most recent evolutionary dupli-
cation of the module 11/12 junction may have given rise
to module 13 and the N terminus of module 14, and then
subsequently to the N-terminal portion of module 15 (Fig-
ure 6). Recombination events involving deletions of whole
modules have been described for the polyene polyketide
nystatin from Streptomyces sp. and have been postulated
for the cyclic pentapeptide nodularin from cyanobacteria
species [48, 49]. In these cases, the evolutionarily related
biosynthetic gene clusters were identified, and their prod-230 Chemistry & Biology 14, 221–233, February 2007 ª2007 Elsucts were characterized. Spirangienes have been de-
tected in a number of S. cellulosum strains [10], and rese-
quencing of the corresponding biosynthetic gene clusters
as well as screening for putative ancestral spirangienes of
shorter lengths should give further insight into the devel-
opment of the present biosynthetic gene cluster.
These examples highlight how rearrangements within
the modular megasynthetase systems can lead to the de-
velopment of new secondary metabolites that may offer
evolutionary benefits for the producer. A second way to ex-
pand the biosynthetic potential of a species is the horizon-
tal gene transfer of secondary metabolic genes among re-
lated but also divergent taxa [50, 51]. An indication for
horizontal gene transfer is the presence of transposase-
like sequences adjacent to bacterial biosynthetic gene
loci [50]. Remnants of such a transposase-encoding gene
are also located in the 50 region of the spirangien biosyn-
thetic gene locus (Figure 1A). In the case of spirangien, Na-
ture has apparently used both horizontal transfer and gene
duplication to evolve the present biosynthetic cluster.
SIGNIFICANCE
The spirangienes produced by S. cellulosum So ce90
are highly cytotoxic and antifungal natural products.
The analysis of the biosynthetic gene cluster provides
important insights into the corresponding and, to our
knowledge, novel biosynthetic pathway by which
thesemetabolites are formed. Direct evidence is given
that two cytochrome P450 monooxygenases are in-
volved in the formationof thecentral spiroketalmoiety.
Genetic engineering of the biosynthetic gene locus re-
sulted in the production of novel, to our knowledge,
acyclic analogs as well as two different desmethyl de-
rivatives. Large stretches of DNA sequence repeats
have been identified within the gene cluster. Taken to-
gether with the presence of remnants of a transpo-
sase-encodinggene, thisfindingprovidessomeexpla-
nation for the way the spirangien biosynthetic gene
cluster has developed during evolution. The detailed
analysis of this biosynthetic gene locus also has rele-
vance for understanding more general aspects of
PKS mechanism and evolution. Such analyses still
continue to reveal new biosynthetic aspects, despite
the great progress that has been made in the last two
decades. Combinatorial biosynthesis has been prac-
ticed byNature ever since,making use of deletions, in-
activations, insertions, and duplications for the gener-
ation of new and potent compounds. Understanding in
detail how this is achieved during the course of evolu-
tion will hopefully allow us to better harness combina-
torial biosynthesis in the laboratory for use in drug
discovery.
EXPERIMENTAL PROCEDURES
Strains and Culture Conditions
S. cellulosum So ce90 was grown at 30C with 170 rpm in liquid G51t
medium [52]. After conjugation on P agar plates [11], cells were platedevier Ltd All rights reserved
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(Marcor), 0.15% MgSO4 3 7 H20, 50 mM HEPES (Serva), 1.5% agar
(Difco) (pH adjusted to 7.4 with KOH). After autoclaving, 10 ml/l sterile
solutions of 5% NH4SO4, 10% CaCl23 2 H2O, 0.08% Fe-EDTA (Fluka),
0.625% K2HPO4, glucose (35%), 1.04% Na-dithionite (Merck), and
10% autoclaved liquid culture of S. cellulosum So ce90 were added.
For the analysis of secondary metabolites, S. cellulosum So ce90
was cultivated in liquid E medium [53]. If required, the media were sup-
plemented with 150 mg/ml hygromycin B and 120 mg/ml tobramycin.
E. coli DH10B, E. coli SURE, and E. coli ET12567/pUZ8002 were
grown in LB medium at 37C. E. coli strains containing cosmids
were grown at 30C. Antibiotics were used at the following concentra-
tions: 100 mg/ml hygromycin B, 50 mg/ml kanamycin sulfate, 50 mg/ml
ampicillin.
DNA Isolation, Manipulation, Analysis, and PCR
All restriction enzymes were purchased from MBI Fermentas. Genomic
DNA of S. cellulosum So ce90 was isolated by using the Puregene Ge-
nomic DNA Purification Kit (Gentra) according to the manufacturer’s
protocol. Southern Blot analysis of genomic DNA was performed by
following the standard protocol of the DIG DNA labeling and detection
kit (Roche Diagnostics). Plasmid DNA purification was performed by
using the NucleoSpin Plasmid Kit (Macherey-Nagel). Polymerase
chain reaction (PCR) was carried out by using Taq DNA-Polymerase
(MBI Fermentas). DMSO and glycerol were added to the reaction mix-
ture to final concentrations of 5% and 2.5%, respectively. Conditions
for amplification with an Eppendorf Mastercycler gradient thermal cy-
cler were as follows: denaturation, 30 s at 95C; annealing, 30 s at 55–
63C; extension, 50–90 s at 72C for 30 cycles, and a final extension for
10 min at 72C. PCR products were purified with the NucleoSpin Plas-
mid Kit (Macherey-Nagel).
PCR products generated for the construction of inactivation plas-
mids were verified by sequencing. The cosmid library was made by us-
ing partially digested (SauIIIAI) genomic DNA of S. cellulosum So ce90,
which was size fractionated with 3% agarose gels and cloned into the
predigested (BamHI-XbaI) SuperCos vector (Stratagene). Ligations
were packaged by using the Gigapack III Gold Packaging extract
(Stratagene) and were transfected into E. coli SURE (Stratagene) ac-
cording to the manufacturer’s protocol.
All other DNA manipulations were performed according to standard
protocols [54]. DNA and amino acid sequence analysis was carried out
by using the VectorNTI software package (Invitrogen) and the Laser-
gene software package (DNASTAR, Inc.). Comparison with GenBank
data was performed with BLAST.
For detailed information about the construction of plasmids, see
Table S1.
Screening of the Cosmid Library
Screening of the cosmid library was performed as previously de-
scribed [17].
Gene Inactivation in Sorangium cellulosum So ce90
Constructs for gene inactivation were based on pSUPHyg containing
a homologous fragment for recombination (see Supplemental Data)
and were conjugated into S. cellulosum So ce90 as described previ-
ously [52]. Transformants were selected on PM agar plates containing
hygromycin B and tobramycin, and single colonies became visible af-
ter 10–14 days. Mutants were analyzed for the correct integration of
the plasmids by Southern blot hybridization, after digestion with ap-
propriate restriction endonucleases.
Analysis of Secondary Metabolite Production
S. cellulosum So ce90 and mutants were grown in E medium with 1%
XAD adsorber resin (Rohmer and Haas) for at least 14 days. XAD beads
and cells were harvested by centrifugation and extracted successively
with acetone and methanol. The combined extracts were evaporated
and redissolved in methanol, resulting in a 100-fold concentration of
the original culture volume. Extracts were analyzed by using HPLC-Chemistry & Biology 14, 221–MS. Separation was carried out with an Agilent 1100 series system
equipped with a photodiode array detector and coupled to a Bruker
HCT plus mass spectrometer operating in negative ionization mode
at a scan range from m/z = 100–1100. A 125 3 2 mm Nucleodur
C18/3 mm RP column (Macherey-Nagel) was used for separation
with a solvent system consisting of H2O (A) and acetonitrile (B), each
containing 0.1% formic acid. The following gradient was applied:
0–2 min 35% B, 2–15 min linear from 35% B to 75% B, 15–25 min iso-
cratic at 75% B, 25–30 min linear from 75% B to 95% B, 30–33 min iso-
cratic at 95% B. Spirangienes were identified by MS analysis (spiran-
gien A and cis/trans isomers: Rt 19.5–20.4 min, [MH] = 701.5;
spirangien B and cis/trans isomers: Rt 21.6–22.8 min, [MH] = 715.5).
Feeding of Labeled Precursors, Purification, and NMR Analysis
of Desmethyl Derivatives
The mutants BFSB, BFSK, and the wild-type were grown in 500 ml E
medium with 1% XAD supplemented with L-[methyl-13C]methionine
(1 mM final concentration), added in three portions at 4, 7, and 9
days. XAD beads and cells were harvested by centrifugation and ex-
tracted with methanol. After evaporation of the organic solvent, the re-
maining aqueous phase was extracted with ethyl acetate. The organic
phase was evaporated, and the remaining oily residue was redissolved
in methanol and extracted with heptane. The methanolic phase was
concentrated and chromatographed with methanol on Sephadex LH
20 (Amersham Biosciences). Spirangien-containing fractions were
combined, evaporated, and analyzed by NMR. NMR spectra were re-
corded at 125.7 MHz on a Bruker Advance 500 with CD3OD as solvent
and internal standard (see Figure S4). 13C enrichments of 3-OMe and
23-OMe after feeding of L-[methyl-13C]methionine were calculated in
comparison to natural abundance. The enrichments of 3-OMe and
23-OMe were found to be 5.5-fold and 8.4-fold, respectively.
Isolation and NMR Analysis of Seco Spirangienes
A shaking flask fermentation (4 l) of JKB19 cultivated in the presence of
100 ml adsorber resin XAD-16 (Rohm and Haas) was passed through
a sieve to recover the resin. The resin was washed with water, trans-
ferred to a glass column, and eluted with 800 ml methanol. The extract
was evaporated to dryness to yield 3.6 g of a crude product. The res-
idue was diluted with water and extracted three times with ethyl ace-
tate. The combined organic layers were dried with sodium sulfate
and evaporated in vacuo to yield 2.4 g of an oily residue. The resulting
extract was partitioned between methanol and n-heptane to give an
extract (1.59 g) that was separated by chromatography on Sephadex
LH-20 (Fluka) with dichloromethane:methanol at a ratio of 8:2 as eluent
(column, 73 71 cm; flow, 3.5 ml/min; UV detection, 313 nm). The spi-
rangien-containing fraction (0.66 g) was further separated by MPLC
(ODS AQ C18 16 mm, 3 3 48 cm, Kronlab) (flow, 13 ml/min; metha-
nol:50 mM ammonium acetate buffer [pH 6.5], 75:25; UV detection:
313 nm). A further fine separation (C18 7 mm, 2503 21 mm, Nucleosil)
(flow, 12 ml/min; acetonitrile:50 mM ammonium acetate buffer [pH
5.0], 58:42; UV detection, 313 nm) gave 3.1 mg seco spirangien A
and 6.0 mg seco spirangien glycoside.
UV, Shimadzu UV2102 PC UV/VIS scanning spectrometer; solvent,
methanol (Merck); ESI-HPLC-MS, PE Siex API 2000 LC-MS; mass
spectrometer, Micromass ESI QTOF; NMR, Bruker ARX 600 spec-
trometer (1H: 600 MHz and 13C: 150 MHz).
Structural Data on Seco Spirangienes
Seco Spirangien A
Rt = 18.2 min (analytical HPLC). UV (MeOH): lmax (lg3) = 308 (4.21), 320
(4.50), 336 (4.67), 354 (4.62). 1H and 13C NMR: see Table S2. ESI MS:
m/z (%): M+H+ 707 (100%), MH+ 705 (100%). HRMS (ESI) for
C41H70O9 [M+Na]
+ calc’d. 729.4917; found 729.4935.
Seco 25 O-Spirangien A Furanoside
Rt = 17.0 min (analytical HPLC). UV data are identical to those of seco
spirangien A. 1H and 13C NMR (only data differing from those for seco
spirangien A are given): 1H NMR: d = 1.60–1.57a, 1.60–1.57b (22-H2);
3.59 (23-H); 2.11 (24 H); 3.74 (25 H); 1.94 (26-H) ddq 7.2, 6.8, 13.9;233, February 2007 ª2007 Elsevier Ltd All rights reserved 231
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Spiroketal Polyketide Formation in S. cellulosum5.10 (10-H) d 1.9; 4.05 (20-H) m; 3.92 (30-H) dd 5.7, 5.7; 4.07 (40-H) m;
3.75 (50-Ha), m; 3.66 (50-Hb) dd 5.3, 11.7 ppm. 13C NMR: d = 38.1
(C-22), 79.4 (C-23), 38.0 (C-24), 82.5 (C-25), 36.9 (C-26), 110.0 (C-10),
82.2 (C-20), 77.1 (C-30 ), 85.4 (C-40), 62.0 (C-50). ESI MS m/z (%):
M+NH4
+ 856.2 (100%), MH+ 836.9 (100%). HRMS (ESI) for
C46H78O13 [M+Na]
+: calc’d. 861.5340; found 861.5387.
Supplemental Data
Supplemental Data include a phylogenetic tree of AT domains (Fig-
ure S1), an alignment of the DH domain core regions (Figure S2), a phy-
logenetic tree of DH domains (Figure S3), 13C NMR signals for methoxy
groups in the spirangienes (Figure S4), details on the construction of
plasmids (Table S1), and 13C and 1H NMR data of seco spirangien (Ta-
ble S2) and are available at http://www.chembiol.com/cgi/content/full/
14/2/221/DC1/.
ACKNOWLEDGMENTS
We thank K. Gerth for help in cultivating S. cellulosum So ce90 and
HPLC analysis and S.C. Wenzel, H.B. Bode, and K.J. Weissman for
helpful comments regarding this manuscript. Research in R.M.’s labo-
ratory was supported by grants from the German Bundesministerium
fu¨r Bildung und Forschung and the Deutsche Forschungsgemein-
schaft.
Received: October 18, 2006
Revised: November 20, 2006
Accepted: November 27, 2006
Published: February 23, 2007
REFERENCES
1. Newman, D., Cragg, G., and Snader, K. (2003). Natural products
as sources of new drugs over the period 1981–2002. J. Nat.
Prod. 66, 1022–1037.
2. Staunton, J., and Weissman, K.J. (2001). Polyketide biosynthesis:
a millennium review. Nat. Prod. Rep. 18, 380–416.
3. Weissman, K.J., and Leadlay, P.F. (2005). Combinatorial biosyn-
thesis of reduced polyketides. Nat. Rev. Microbiol. 3, 925–936.
4. Rix, U., Fischer, C., Remsing, L.L., and Rohr, J. (2002). Modifica-
tion of post-PKS tailoring steps through combinatorial biosynthe-
sis. Nat. Prod. Rep. 19, 542–580.
5. Khosla, C., and Tang, Y. (2005). A new route to designer antibi-
otics. Science 308, 367–368.
6. Clardy, J., and Walsh, C. (2004). Lessons from natural molecules.
Nature 432, 829–837.
7. Moss, S.J., Martin, C.J., and Wilkinson, B. (2004). Loss of co-line-
arity by modular polyketide synthases: a mechanism for the evolu-
tion of chemical diversity. Nat. Prod. Rep. 21, 575–593.
8. Wenzel, S.C., and Mu¨ller, R. (2005). Formation of novel secondary
metabolites by bacterial multimodular assembly lines: deviations
from text book biosynthetic logic. Curr. Opin. Chem. Biol. 9,
447–458.
9. Bode, H.B., and Mu¨ller, R. (2005). The impact of bacterial geno-
mics on natural product research. Angew. Chem. Int. Ed. 44,
6828–6846.
10. Gerth, K., Pradella, S., Perlova, O., Beyer, S., and Mu¨ller, R. (2003).
Myxobacteria: proficient producers of novel natural products with
various biological activities—past and future biotechnological as-
pects with the focus on the genus Sorangium. J. Biotechnol. 106,
233–253.
11. Pradella, S., Hans, A., Sproer, C., Reichenbach, H., Gerth, K., and
Beyer, S. (2002). Characterisation, genome size and genetic ma-
nipulation of the myxobacterium Sorangium cellulosum So ce56.
Arch. Microbiol. 178, 484–492.232 Chemistry & Biology 14, 221–233, February 2007 ª2007 El12. Kopp, M., Irschik, H., Gross, F., Perlova, O., Sandmann, A., Gerth,
K., and Mu¨ller, R. (2004). Critical variations of conjugational DNA
transfer into secondary metabolite multiproducing Sorangium cel-
lulosum strains So ce12 and So ce56: development of a mariner-
based transposon mutagenesis system. J. Biotechnol. 107,
29–40.
13. Molnar, I., Schupp, T., Ono, M., Zirkle, R., Milnamow, M., Nowak-
Thompson, B., Engel, N., Toupet, C., Stratmann, A., Cyr, D.D.,
et al. (2000). The biosynthetic gene cluster for the microtubule-sta-
bilizing agents epothilones A and B from Sorangium cellulosum So
ce90. Chem. Biol. 7, 97–109.
14. Julien, B., Shah, S., Ziermann, R., Goldman, R., Katz, L., and Kho-
sla, C. (2000). Isolation and characterization of the epothilone bio-
synthetic gene cluster from Sorangium cellulosum. Gene 249,
153–160.
15. Ho¨fle, G., and Reichenbach, H. (2005). Epothilone, a myxobacterial
metabolite with promising antitumor activity. In Anticancer Agents
from Natural Products, G.M. Cragg, D.G. Kingston, and D.J. New-
man, eds. (Boca Raton, FL: Taylor & Francis), pp. 413–450.
16. Niggemann, J., Bedorf, N., Flo¨rke, U., Steinmetz, H., Gerth, K.,
Reichenbach, H., and Ho¨fle, G. (2005). Spirangien A and B, highly
cytotoxic and antifungal spiroketals from the myxobacterium Sor-
angium cellulosum: isolation, structure elucidation and chemical
modifications. Eur. J. Org. Chem. 2005, 5013–5018.
17. Beyer, S., Kunze, B., Silakowski, B., and Mu¨ller, R. (1999). Meta-
bolic diversity in myxobacteria: identification of the myxalamid
and the stigmatellin biosynthetic gene cluster of Stigmatella auran-
tiaca Sg a15 and a combined polyketide-(poly)peptide gene clus-
ter from the epothilone producing strain Sorangium cellulosum So
ce90. Biochim. Biophys. Acta 1445, 185–195.
18. Gaitatzis, N., Silakowski, B., Kunze, B., Nordsiek, G., Blo¨cker, H.,
Ho¨fle, G., and Mu¨ller, R. (2002). The biosynthesis of the aromatic
myxobacterial electron transport inhibitor stigmatellin is directed
by a novel type of modular polyketide synthase. J. Biol. Chem.
277, 13082–13090.
19. Silakowski, B., Schairer, H.U., Ehret, H., Kunze, B., Weinig, S.,
Nordsiek, G., Brandt, P., Blocker, H., Ho¨fle, G., Beyer, S., and
Mu¨ller, R. (1999). New lessons for combinatorial biosynthesis
from myxobacteria: the myxothiazol biosynthetic gene cluster of
Stigmatella aurantiaca DW4/3–1. J. Biol. Chem. 274, 37391–
37399.
20. Ligon, J., Hill, S., Beck, J., Zirkle, R., Monar, I., Zawodny, J.,
Money, S., and Schupp, T. (2002). Characterization of the biosyn-
thetic gene cluster for the antifungal polyketide soraphen A from
Sorangium cellulosum So ce26. Gene 285, 257–267.
21. Yadav, G., Gokhale, R.S., and Mohanty, D. (2003). Computational
approach for prediction of domain organization and substrate
specificity of modular polyketide synthases. J. Mol. Biol. 328,
335–363.
22. Tang, L., Yoon, Y.J., Choi, C.Y., and Hutchinson, C.R. (1998).
Characterization of the enzymatic domains in the modular polyke-
tide synthase involved in rifamycin B biosynthesis by Amycolatop-
sis mediterranei. Gene 216, 255–265.
23. Reid, R., Piagentini, M., Rodriguez, E., Ashley, G., Viswanathan,
N., Carney, J., Santi, D.V., Hutchinson, C.R., and McDaniel, R.
(2003). A model of structure and catalysis for ketoreductase do-
mains in modular polyketide synthases. Biochemistry 42, 72–79.
24. Caffrey, P. (2003). Conserved amino acid residues correlating with
ketoreductase stereospecificity in modular polyketide synthases.
ChemBioChem 4, 654–657.
25. Baerga-Ortiz, A., Popovic, B., Siskos, A.P., O’Hare, H.M., Spiteller,
D., Williams, M.G., Campillo, N., Spencer, J.B., and Leadlay, P.F.
(2006). Directed mutagenesis alters the stereochemistry of cataly-
sis by isolated ketoreductase domains from the erythromycin pol-
yketide synthase. Chem. Biol. 13, 277–285.sevier Ltd All rights reserved
Chemistry & Biology
Spiroketal Polyketide Formation in S. cellulosum26. Donadio, S., and Katz, L. (1992). Organization of the enzymatic
domains in the multifunctional polyketide synthase involved in
erythromycin formation in Saccharopolyspora erythraea. Gene
111, 51–60.
27. Perlova, O., Gerth, K., Hans, A., Kaiser, O., and Mu¨ller, R. (2006).
Identification and analysis of the chivosazol biosynthetic gene
cluster from the myxobacterial model strain Sorangium cellulosum
So ce56. J. Biotechnol. 121, 174–191.
28. Tang, L., Ward, S., Chung, L., Carney, J.R., Li, Y., Reid, R., and
Katz, L. (2004). Elucidating the mechanism of cis double bond for-
mation in epothilone biosynthesis. J. Am. Chem. Soc. 126, 46–47.
29. Konz, D., and Marahiel, M.A. (1999). How do peptide synthetases
generate structural diversity? Chem. Biol. 6, R39–R48.
30. Keatinge-Clay, A.T., and Stroud, R.M. (2006). The structure of a ke-
toreductase determines the organization of the b-carbon process-
ing enzymes of modular polyketide synthases. Structure 14, 737–
748.
31. Kagan, R.M., and Clarke, S. (1994). Widespread occurrence of
three sequence motifs in diverse S-adenosylmethionine-depen-
dent methyltransferases suggest a common structure for these
enzymes. Arch. Biochem. Biophys. 310, 417–427.
32. Simon, R., O’Connell, M., Labes, M., and Pu¨hler, A. (1986). Plas-
mid vectors for the genetic analysis and manipulation of Rhizobia
and other Gram negative bacteria. Methods Enzymol. 118, 643–
659.
33. Blondelet-Rouault, M.H., Weiser, J., Lebrihi, A., Branny, P., and
Pernodet, J.L. (1997). Antibiotic resistance gene cassettes derived
from the omega interposon for use in E. coli and Streptomyces.
Gene 190, 315–317.
34. Breitmaier, E., and Voelter, W. (1987). Carbon-13 NMR Spectros-
copy, Third Edition (Weinheim, Germany: VCH Verlag).
35. Reichenbach, H., Ho¨fle, G., Bo¨hlendorf, B., and Irschik, H. German
patent DE4305486. August 1994.
36. Ikeda, H., and Omura, S. (1997). Avermectin biosynthesis. Chem.
Rev. 97, 2591–2609.
37. Gallimore, A.R., Stark, C.B., Bhatt, A., Harvey, B.M., Demydchuk,
Y., Bolanos-Garcia, V., Fowler, D.J., Staunton, J., Leadlay, P.F.,
and Spencer, J.B. (2006). Evidence for the role of the monB genes
in polyether ring formation during monensin biosynthesis. Chem.
Biol. 13, 453–460.
38. Heathcote, M.L., Staunton, J., and Leadlay, P.F. (2001). Role of
type II thioesterases: evidence for removal of short acyl chains
produced by aberrant decarboxylation of chain extender units.
Chem. Biol. 8, 207–220.
39. Butler, A.R., Bate, N., and Cundliffe, E. (1999). Impact of thioester-
ase activity on tylosin biosynthesis inStreptomyces fradiae. Chem.
Biol. 6, 287–292.
40. Chen, S., Roberts, J.B., Xue, Y., Sherman, D.H., and Reynolds,
K.A. (2001). The Streptomyces venezuelae pikAV gene contains
a transcription unit essential for expression of enzymes involved
in glycosylation of narbonolide and 10-deoxymethynolide. Gene
263, 255–264.
41. Hu, Z., Pfeifer, B.A., Chao, E., Murli, S., Kealey, J., Carney, J.R.,
Ashley, G., Khosla, C., and Hutchinson, C.R. (2003). A specific
role of the Saccharopolyspora erythraea thioesterase II gene in
the function of modular polyketide synthases. Microbiology 149,
2213–2225.Chemistry & Biology 14, 221–42. Zheng, Z., Gong, Q., Liu, T., Deng, Y., Chen, J.C., and Chen, G.Q.
(2004). Thioesterase II of Escherichia coli plays an important role in
3-hydroxydecanoic acid production. Appl. Environ. Microbiol. 70,
3807–3813.
43. Linne, U., Schwarzer, D., Schroeder, G.N., and Marahiel, M.A.
(2004). Mutational analysis of a type II thioesterase associated
with nonribosomal peptide synthesis. Eur. J. Biochem. 271,
1536–1545.
44. Schwarzer, D., Mootz, H.D., Linne, U., and Marahiel, M.A. (2002).
Regeneration of misprimed nonribosomal peptide synthetases by
type II thioesterases. Proc. Natl. Acad. Sci. USA 99, 14083–14088.
45. Aparicio, J.F., Molnar, I., Schwecke, T., Konig, A., Haydock, S.F.,
Khaw, L.E., Staunton, J., and Leadlay, P.F. (1996). Organization of
the biosynthetic gene cluster for rapamycin in Streptomyces
hygroscopicus: analysis of the enzymatic domains in the modular
polyketide synthase. Gene 169, 9–16.
46. Brautaset, T., Sekurova, O.N., Sletta, H., Ellingsen, T.E., Strm,
A.R., Valla, S., and Zotchev, S.B. (2000). Biosynthesis of the poly-
ene antifungal antibiotic nystatin in Streptomyces noursei ATCC
11455: analysis of the gene cluster and deduction of the biosyn-
thetic pathway. Chem. Biol. 7, 395–403.
47. Stinear, T.P., Mve-Obiang, A., Small, P.L., Frigui, W., Pryor, M.J.,
Brosch, R., Jenkin, G.A., Johnson, P.D., Davies, J.K., Lee, R.E.,
et al. (2004). Giant plasmid-encoded polyketide synthases pro-
duce the macrolide toxin of Mycobacterium ulcerans. Proc. Natl.
Acad. Sci. USA 101, 1345–1349.
48. Brautaset, T., Bruheim, P., Sletta, H., Hagen, L., Ellingsen, T.E.,
Strom, A.R., Valla, S., and Zotchev, S.B. (2002). Hexaene deriva-
tives of nystatin produced as a result of an induced rearrangement
within the nysC polyketide synthase gene in S. noursei ATCC
11455. Chem. Biol. 9, 367–373.
49. Moffitt, M.C., and Neilan, B.A. (2004). Characterization of the nod-
ularin synthetase gene cluster and proposed theory of the evolu-
tion of cyanobacterial hepatotoxins. Appl. Environ. Microbiol. 70,
6353–6362.
50. Lopez, J.V. (2003). Naturally mosaic operons for secondary me-
tabolite biosynthesis: variability and putative horizontal transfer
of discrete catalytic domains of the epothilone polyketide syn-
thase locus. Mol. Genet. Genomics 270, 420–431.
51. Jenke-Kodama, H., Sandmann, A., Mu¨ller, R., and Dittmann, E.
(2005). Evolutionary implications of bacterial polyketide syn-
thases. Mol. Biol. Evol. 22, 2027–2039.
52. Jaoua, S., Neff, S., and Schupp, T. (1992). Transfer of mobilizable
plasmids to Sorangium cellulosum and evidence for their integra-
tion into the chromosome. Plasmid 28, 157–165.
53. Gerth, K., Steinmetz, H., Ho¨fle, G., and Reichenbach, H. (2001).
Studies on the biosynthesis of epothilones: the PKS and epothi-
lone C/D monooxygenase. J. Antibiot. (Tokyo) 54, 144–148.
54. Sambrook, J., and Russell, D.W. (2001). Molecular Cloning: A Lab-
oratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Lab-
oratory Press).
Accession Numbers
The sequence of the Sorangium cellulosum So ce90 spirangien bio-
synthetic gene cluster reported in this paper has been deposited in
the EMBL database with accession code AM407731.233, February 2007 ª2007 Elsevier Ltd All rights reserved 233
